ASCO details how to manage ongoing cancer drug shortageDecember 1, 2023Patient & Survivor CareBreast CancerGenitourinary CancerGastrointestinal CancerHead & Neck/Thyroid CancersGynecologic Cancer
Black men are at higher risk of prostate cancer at younger ages, lower PSA levelsNovember 6, 2023Genitourinary CancerDiversity in Medicine
Enfortumab vedotin/pembrolizumab hailed as new standard for upfront mUCOctober 25, 2023Genitourinary CancerPatient & Survivor Care
Enzalutamide improves metastasis-free survival, QoL in prostate cancerOctober 24, 2023Genitourinary Cancer
Observation, not radiotherapy, after radical prostatectomyOctober 22, 2023Genitourinary CancerPatient & Survivor Care
Short-course SBRT: Standard of care in prostate cancer?October 4, 2023Genitourinary CancerPatient & Survivor Care
Is this the best screening test for prostate cancer?September 11, 2023Genitourinary CancerPreventive Care
BCR is unreliable surrogate for overall survival in prostate cancerSeptember 7, 2023Genitourinary Cancer
Predicting prostate cancer risk: Are polygenic risk scores ready for prime time?September 6, 2023Genitourinary Cancer
Do AI chatbots give reliable answers on cancer? Yes and noSeptember 1, 2023Practice ManagementBreast CancerLung CancerGenitourinary CancerMelanomaGastrointestinal Cancer
